TMAM
MIRM icon

Tokio Marine Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Tokio Marine Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Buy
+873
New +$87.7K ﹤0.01% 523
2024
Q1 		– Sell
-13,051
Closed -$385K – 563
2023
Q4 		$385K Buy
+13,051
New +$395K 0.02% 471

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Tokio Marine Asset Management's MIRM Position: Q2 2026 in Review

Tokio Marine Asset Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 873 shares worth $102K. The stake represents ﹤0.01% of the portfolio and ranks #523 among its holdings. This is a return to the name: Tokio Marine Asset Management previously reported a position in MIRM as recently as Q4 2023.

Tokio Marine Asset Management first reported a position in MIRM in Q4 2023 and has held it in 2 quarters since. The position peaked at $385K in Q4 2023. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Tokio Marine Asset Management held 873 shares of Mirum Pharmaceuticals worth $102K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Tokio Marine Asset Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Tokio Marine Asset Management's portfolio in Q2 2026, its #523 holding.
  • Tokio Marine Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2023 and has held it in 2 quarters since.
  • Tokio Marine Asset Management's Mirum Pharmaceuticals position peaked at $385K in Q4 2023.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Tokio Marine Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.